Leadership Shift at Vetter Signals New Phase in Global GMP Manufacturing Strategy
Ravensburg, Germany — December 3, 2025 — Vetter Pharma-Fertigung GmbH & Co. KG, a global contract development and manufacturing...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Ravensburg, Germany — December 3, 2025 — Vetter Pharma-Fertigung GmbH & Co. KG, a global contract development and manufacturing...
Dateline — NORTHBROOK, Ill., November 10, 2025:Barilla America, Inc., the world’s leading pasta maker, has declared pasta the official...
BOXMEER, The Netherlands — October 23, 2025 — MSD Animal Health, a global leader in veterinary biopharmaceutical innovation, announced...
NEW YORK, November 3, 2025 — CS Interpharm and CS Diagnostics Pharma (CSDX) have announced the completion of a...
NORTH CHICAGO, Ill., November 2, 2025 — AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has raised its annual...
LANGHORNE, Pa., November 2, 2025 — Savara Inc. (Nasdaq: SVRA), a clinical-stage biopharmaceutical company specializing in rare respiratory diseases,...
San Rafael, California — October 30, 2025 — BioMarin Pharmaceutical Inc. announced that the U.S. Food and Drug Administration...
Vancouver, British Columbia & Rehovot, Israel — October 30, 2025 — BioHarvest Sciences Inc. (NASDAQ: BHST) has announced a...
